As of February 2026 Immunovant has a market cap of A$7.25 Billion. This makes Immunovant the world's 3118th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Feb 4th, 2026 the market cap of Immunovant was reported to be: